David Li

1.1k total citations · 1 hit paper
25 papers, 495 citations indexed

About

David Li is a scholar working on Physiology, Surgery and Molecular Biology. According to data from OpenAlex, David Li has authored 25 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in David Li's work include Knee injuries and reconstruction techniques (5 papers), Alzheimer's disease research and treatments (4 papers) and Spaceflight effects on biology (4 papers). David Li is often cited by papers focused on Knee injuries and reconstruction techniques (5 papers), Alzheimer's disease research and treatments (4 papers) and Spaceflight effects on biology (4 papers). David Li collaborates with scholars based in Canada, United States and United Kingdom. David Li's co-authors include Syun‐Ru Yeh, Denis L. Rousseau, Dennis J. Stuehr, Bradley B. Pua, Shobha Dhadda, Michael C. Irizarry, David C. Madoff, Lynn D. Kramer, Chad J. Swanson and C. S. Kabir and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biological Psychiatry.

In The Last Decade

David Li

23 papers receiving 486 citations

Hit Papers

The AHEAD 3‐45 Study: Design of a prevention trial for Al... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Li Canada 12 277 98 91 64 48 25 495
Carole Quesada United States 17 132 0.5× 217 2.2× 39 0.4× 18 0.3× 44 0.9× 35 701
Ivan Mikula Croatia 12 168 0.6× 103 1.1× 31 0.3× 59 0.9× 21 0.4× 36 456
Huajie Li China 16 170 0.6× 214 2.2× 58 0.6× 28 0.4× 36 0.8× 45 657
Victor Sung United States 12 42 0.2× 122 1.2× 65 0.7× 38 0.6× 34 0.7× 26 765
Steven Kerr United States 10 206 0.7× 154 1.6× 21 0.2× 28 0.4× 13 0.3× 15 498
Hikaru Sakamoto Japan 13 83 0.3× 223 2.3× 24 0.3× 16 0.3× 44 0.9× 36 677
David C. Calvin United States 10 123 0.4× 192 2.0× 272 3.0× 51 0.8× 35 0.7× 12 729
Yuxiang Han China 15 69 0.2× 291 3.0× 33 0.4× 30 0.5× 19 0.4× 38 690
Xinyi Lv China 12 95 0.3× 135 1.4× 49 0.5× 24 0.4× 9 0.2× 56 467
Qiaojuan Zhang United States 15 172 0.6× 198 2.0× 8 0.1× 32 0.5× 26 0.5× 24 595

Countries citing papers authored by David Li

Since Specialization
Citations

This map shows the geographic impact of David Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Li more than expected).

Fields of papers citing papers by David Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Li. The network helps show where David Li may publish in the future.

Co-authorship network of co-authors of David Li

This figure shows the co-authorship network connecting the top 25 collaborators of David Li. A scholar is included among the top collaborators of David Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Li. David Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sperling, Reisa A., Shobha Dhadda, David Li, et al.. (2024). Is there Evidence for a Continued Benefit for Long‐Term Lecanemab Treatment? A Benefit/Risk Update from Long‐Term Efficacy, Safety and Biomarker Data. Alzheimer s & Dementia. 20(S6). 3 indexed citations
3.
Li, David, et al.. (2024). Short-term response of primary human meniscus cells to simulated microgravity. Cell Communication and Signaling. 22(1). 342–342. 2 indexed citations
4.
Li, David, et al.. (2023). Transcriptomic response of bioengineered human cartilage to parabolic flight microgravity is sex-dependent. npj Microgravity. 9(1). 5–5. 8 indexed citations
5.
Li, David, Alexander R. A. Szojka, Melanie Kunze, et al.. (2023). Non-hypertrophic chondrogenesis of mesenchymal stem cells through mechano-hypoxia programing. Journal of Tissue Engineering. 14. 1778662878–1778662878. 3 indexed citations
6.
Li, David, et al.. (2022). Engineered Human Meniscus in Modeling Sex Differences of Knee Osteoarthritis in Vitro. Frontiers in Bioengineering and Biotechnology. 10. 823679–823679. 14 indexed citations
7.
Li, David, Melanie Kunze, Aillette Mulet‐Sierra, et al.. (2022). Mechanical Unloading of Engineered Human Meniscus Models Under Simulated Microgravity: A Transcriptomic Study. Scientific Data. 9(1). 736–736. 8 indexed citations
8.
Dhadda, Shobha, Michio Kanekiyo, David Li, et al.. (2022). Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer’s disease. Alzheimer s Research & Therapy. 14(1). 182–182. 25 indexed citations
9.
Rafii, Michael S., Reisa A. Sperling, Michael Donohue, et al.. (2022). The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease. Alzheimer s & Dementia. 19(4). 1227–1233. 130 indexed citations breakdown →
10.
Szojka, Alexander R. A., David Li, Melanie Kunze, et al.. (2021). Mechano-Hypoxia Conditioning of Engineered Human Meniscus. Frontiers in Bioengineering and Biotechnology. 9. 739438–739438. 12 indexed citations
11.
Li, David, et al.. (2021). Quantitative analysis of regional specific pelvic symmetry. Medical & Biological Engineering & Computing. 59(2). 369–381. 5 indexed citations
12.
Szojka, Alexander R. A., Rita de Cássia Marqueti, David Li, et al.. (2021). Human engineered meniscus transcriptome after short-term combined hypoxia and dynamic compression. Journal of Tissue Engineering. 12. 2753720250–2753720250. 11 indexed citations
13.
Eijk, Yvette van der, et al.. (2021). E-Cigarette Markets and Policy Responses in Southeast Asia: A Scoping Review. International Journal of Health Policy and Management. 11(9). 1616–1624. 32 indexed citations
14.
Swanson, Chad J., Shobha Dhadda, David Li, et al.. (2021). Lecanemab, an anti-Aβ protofibril antibody: Updated data from a randomized, double-blind phase 2B proof of concept clinical trial and open-label extension in early Alzheimer's disease. Journal of the Neurological Sciences. 429. 117847–117847. 2 indexed citations
15.
Cornman‐Homonoff, Joshua, David Li, & Marc Schiffman. (2017). Pre-operative renal artery embolization and suprarenal IVC filter placement for prevention of fat embolization in renal angiomyolipoma with venous extension. Clinical Imaging. 43. 24–27. 6 indexed citations
16.
Ivanoiu, Adrian, Jérémie Pariente, Kevin Booth, et al.. (2016). Long-term safety and tolerability of bapineuzumab in patients with Alzheimer’s disease in two phase 3 extension studies. Alzheimer s Research & Therapy. 8(1). 24–24. 33 indexed citations
17.
Li, David, Bradley B. Pua, & David C. Madoff. (2014). Role of Embolization in the Treatment of Renal Masses. Seminars in Interventional Radiology. 31(1). 70–81. 32 indexed citations
18.
Li, David, Eric Y. Hayden, Koustubh Panda, et al.. (2006). Regulation of the Monomer-Dimer Equilibrium in Inducible Nitric-oxide Synthase by Nitric Oxide. Journal of Biological Chemistry. 281(12). 8197–8204. 27 indexed citations
19.
Li, David, Dennis J. Stuehr, Syun‐Ru Yeh, & Denis L. Rousseau. (2004). Heme Distortion Modulated by Ligand-Protein Interactions in Inducible Nitric-oxide Synthase. Journal of Biological Chemistry. 279(25). 26489–26499. 60 indexed citations
20.
Clark, Campbell M., et al.. (1993). Metabolic subtypes in patients with schizophrenia. Biological Psychiatry. 33(2). 86–92. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026